These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37817391)

  • 1. A case of cytomegalovirus-induced haemorrhagic cystitis during treatment of pemphigus foliaceus with corticosteroids and azathioprine.
    Hayashi W; Adachi A; Naito A; Suzuki M; Sawada Y
    Australas J Dermatol; 2023 Nov; 64(4):e394-e396. PubMed ID: 37817391
    [No Abstract]   [Full Text] [Related]  

  • 2. Life-threatening course of pemphigus vulgaris complicated by sepsis caused by azathioprine-induced bone marrow suppression, successfully managed with combination therapy.
    Tichy M; Urbanek J; Sternbersky J; Ditrichova D; Hercogova J
    Dermatol Ther; 2014; 27(3):183-6. PubMed ID: 24283408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutropenic fever with diffuse alopecia in a patient with pemphigus foliaceus during azathioprine treatment.
    Kim WI; Park TH; Yoon SY; Whang KU; Cho MK; Kim S
    Dermatol Ther; 2020 Jul; 33(4):e13466. PubMed ID: 32338417
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of the immunobullous disorders. II. Pemphigus.
    Huilgol SC; Black MM
    Clin Exp Dermatol; 1995 Jul; 20(4):283-93. PubMed ID: 8548984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus on the treatment of autoimmune bullous dermatoses: pemphigus vulgaris and pemphigus foliaceus - Brazilian Society of Dermatology.
    Porro AM; Hans Filho G; Santi CG
    An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):20-32. PubMed ID: 31166407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined immunosuppressive therapy in patients with pemphigus vulgaris and its side effects].
    Vojácková N; Hejcmanová I; Schmiedbergerová R; Hercogová J
    Cas Lek Cesk; 2005; 144(12):833-5. PubMed ID: 16389757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A blistering response: concurrent psoriasis and pemphigus foliaceus.
    Kurtzman DJ; Christopher M; Lian F; Sligh JE
    Am J Med; 2015 Jan; 128(1):24-6. PubMed ID: 25239159
    [No Abstract]   [Full Text] [Related]  

  • 8. Pemphigus.
    Schmidt E; Kasperkiewicz M; Joly P
    Lancet; 2019 Sep; 394(10201):882-894. PubMed ID: 31498102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous neosporosis during treatment of pemphigus foliaceus in a dog.
    Ordeix L; Lloret A; Fondevila D; Dubey JP; Ferrer L; Fondati A
    J Am Anim Hosp Assoc; 2002; 38(5):415-9. PubMed ID: 12220024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early development of disseminated nocardiosis during immunosuppressive treatment for pemphigus vulgaris.
    Carducci M; Nosotti L; Calcaterra R; Bonifati C; Mussi A; Pelagalli L; Di Emidio L; Laurenzi L; Russo A; Franco G; Toma L; Morrone A
    Eur J Dermatol; 2007; 17(4):346-7. PubMed ID: 17540653
    [No Abstract]   [Full Text] [Related]  

  • 11. NUDT15 polymorphism and severe azathioprine-induced myelosuppression in a Chinese man with pemphigus vulgaris.
    Yan W; Zhou YH; Wang L; Xiao J; Li W
    Br J Dermatol; 2018 Jan; 178(1):e40-e41. PubMed ID: 28733976
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study.
    Rose E; Wever S; Zilliken D; Linse R; Haustein UF; Bröcker EB
    J Dtsch Dermatol Ges; 2005 Mar; 3(3):200-6. PubMed ID: 16372814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porokeratosis and immunosuppressive treatment for pemphigus foliaceus.
    Leibovici V; Zeidenbaum M; Goldenhersh M
    J Am Acad Dermatol; 1988 Nov; 19(5 Pt 1):910-1. PubMed ID: 3192775
    [No Abstract]   [Full Text] [Related]  

  • 14. Herpes esophagitis in the setting of immunosuppression from pemphigus vulgaris therapy.
    Kahn NH; Friedmann DP; Phillips CM
    Cutis; 2015 Jan; 95(1):44-6. PubMed ID: 25671444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies.
    Zhao W; Wang J; Zhu H; Pan M
    Clin Rev Allergy Immunol; 2021 Dec; 61(3):351-362. PubMed ID: 34350539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strongyloidiasis complicating immunosuppression for pemphigus vulgaris.
    Walker SL; Mann TA
    Br J Dermatol; 2013 Dec; 169(6):1363-4. PubMed ID: 23855642
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes mellitus induced in a dog after administration of corticosteroids and methylprednisolone pulse therapy.
    Jeffers JG; Shanley KJ; Schick RO
    J Am Vet Med Assoc; 1991 Jul; 199(1):77-80. PubMed ID: 1885333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of pemphigus foliaceus. A fatal case resulting from side effects of corticoids].
    Watanabe S; Komura J; Adachi T
    Hifuka Kiyo; 1966 Feb; 61(1):6-15. PubMed ID: 5949314
    [No Abstract]   [Full Text] [Related]  

  • 19. Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil.
    Biot Sdel R; Franco JP; Lima RB; Pereira HN; Marques LP; Martins CJ
    An Bras Dermatol; 2014; 89(6):980-4. PubMed ID: 25387507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pemphigus vulgaris. Clinical aspects, pathophysiology and therapy of a bullous autoimmune dermatosis].
    Sunderkötter CH; Luger TA
    Med Monatsschr Pharm; 1995 Sep; 18(9):255-63. PubMed ID: 7476660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.